During the past decade, Universitätsklinikum Hamburg-Eppendorf, Klinik für Innere Medizin conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Hamburg-Eppendorf, Klinik für Innere Medizin" #1 collaborator was "Hannover Medical School" with 2 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Hamburg-Eppendorf, Klinik für Innere Medizin" are "Basal Cell Carcinoma" (1 trials), "Hepatitis C, Chronic" (1 trials), "Hepatitis D" (1 trials) and "Malignant Melanoma" (1 trials). Many other conditions were trialed in "Universitätsklinikum Hamburg-Eppendorf, Klinik für Innere Medizin" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Hamburg-Eppendorf, Klinik für Innere Medizin" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "PEG-IFN alfa-2a, Tenofovir" (1 trials), "PEG-IFN alfa-2a, placebo" (1 trials), "Ribavirin" (1 trials), "Vemurafenib" (1 trials) and "pegylated Interferon alpha-2b" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Hamburg-Eppendorf, Klinik für Innere Medizin" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsklinikum Hamburg-Eppendorf, Klinik für Innere Medizin". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Universitätsklinikum Hamburg-Eppendorf, Klinik für Innere Medizin, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Hamburg-Eppendorf, Klinik für Innere Medizin, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".